NEW YORK, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of ...

SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER ...

Transcarotid artery revascularization (TCAR), which pulls in both surgical and endovascular techniques, is being rapidly adopted in the United States for the treatment of high-risk patients with ...

MIAMI, June 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There have now been more than 100,000 transcarotid ...

ST. LOUIS – Carotid artery disease is a build-up of plaque in the two main arteries of the neck, which are vital in feeding oxygen-rich blood to the brain. When plaque builds up in the carotid ...

Patients with carotid stenosis at high risk for stroke face a difficult decision. Carotid endarterectomy has for decades been the gold-standard treatment, while the less-invasive carotid stenting has ...

Add Yahoo as a preferred source to see more of our stories on Google. EXETER – Core Vascular Surgeons at Exeter Hospital recently performed their first TransCarotid Artery Revascularization (TCAR) ...

Please provide your email address to receive an email when new articles are posted on . In two real-world studies presented at the Society for Vascular Surgery Vascular Annual Meeting, transcarotid ...

InspireMD, Inc. NSPR announced positive 30-day results from the CGUARDIANS II clinical trial evaluating its CGuard Prime 80 ...